Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Watschinger

Showing results (61-70 of 74) with videos related to

Pageof 8
Sort By:
Nephron|January 1, 1992
Treatment of hyperlipidemic kidney graft recipients with lovastatin: effect on LDL-cholesterol and lipoprotein (a)O Traindl, S Reading, M Franz, et al.
Urology|May 20, 1998
Role of magnetic resonance imaging in renal transplant recipients with acquired cystic kidney diseaseG Heinz-Peer, A Maier, K Eibenberger, et al.
Transplantation Proceedings|February 1, 1989
OKT3 monoclonal antibody treatment in renal transplant recipients--clinical experience in 49 patientsJ Kovarik, G J Zlabinger, J Wolfram, et al.
Critical Care Medicine|March 1, 1993
Atrial natriuretic peptide release in response to different positive end-expiratory pressure levelsM Frass, B Watschinger, O Traindl, et al.
Transplantation Proceedings|December 1, 1992
Is determination of PP 65 useful for early diagnosis of cytomegalovirus infection in renal transplantation?R Klauser, H Kotzmann, P Wamser, et al.
The Journal of Infectious Diseases|June 6, 2000
Monitoring the virus load can predict the emergence of drug-resistant hepatitis B virus strains in renal transplantation patients during lamivudine therapyE Puchhammer-Stöckl, C W Mandl, J Kletzmayr, et al.
Journal of Clinical Immunology|May 1, 1992
Cytokine release and dynamics of leukocyte populations after CD3/TCR monoclonal antibody treatmentG J Zlabinger, K M Stuhlmeier, R Eher, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|August 10, 2000
Long-term evaluation of proliferative donor antigen-specific reactivity in cadaveric kidney transplant recipientsG A Böhmig, M D Säemann, M Bergmann, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 31, 2000
Role of humoral immune reactions as target for antirejection therapy in recipients of a spousal-donor kidney graftG A Böhmig, H Regele, M D Säemann, et al.
Transplantation|March 15, 1996
The effects of nondepleting CD4 targeted therapy in presensitized rat recipients of cardiac allograftsJ Binder, M Lehmann, E Graser, et al.
Pageof 8

Showing results (61-70 of 74) with videos related to

Sort By:
Pageof 8
Nephron|January 1, 1992
Treatment of hyperlipidemic kidney graft recipients with lovastatin: effect on LDL-cholesterol and lipoprotein (a)O Traindl, S Reading, M Franz, et al.
Urology|May 20, 1998
Role of magnetic resonance imaging in renal transplant recipients with acquired cystic kidney diseaseG Heinz-Peer, A Maier, K Eibenberger, et al.
Transplantation Proceedings|February 1, 1989
OKT3 monoclonal antibody treatment in renal transplant recipients--clinical experience in 49 patientsJ Kovarik, G J Zlabinger, J Wolfram, et al.
Critical Care Medicine|March 1, 1993
Atrial natriuretic peptide release in response to different positive end-expiratory pressure levelsM Frass, B Watschinger, O Traindl, et al.
Transplantation Proceedings|December 1, 1992
Is determination of PP 65 useful for early diagnosis of cytomegalovirus infection in renal transplantation?R Klauser, H Kotzmann, P Wamser, et al.
The Journal of Infectious Diseases|June 6, 2000
Monitoring the virus load can predict the emergence of drug-resistant hepatitis B virus strains in renal transplantation patients during lamivudine therapyE Puchhammer-Stöckl, C W Mandl, J Kletzmayr, et al.
Journal of Clinical Immunology|May 1, 1992
Cytokine release and dynamics of leukocyte populations after CD3/TCR monoclonal antibody treatmentG J Zlabinger, K M Stuhlmeier, R Eher, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|August 10, 2000
Long-term evaluation of proliferative donor antigen-specific reactivity in cadaveric kidney transplant recipientsG A Böhmig, M D Säemann, M Bergmann, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 31, 2000
Role of humoral immune reactions as target for antirejection therapy in recipients of a spousal-donor kidney graftG A Böhmig, H Regele, M D Säemann, et al.
Transplantation|March 15, 1996
The effects of nondepleting CD4 targeted therapy in presensitized rat recipients of cardiac allograftsJ Binder, M Lehmann, E Graser, et al.
Pageof 8